Zhiguo Luo

Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB-I...

Vibostolimab-pembrolizumab versus pembrolizumab als adjuvante therapie bij hoogrisico stadium IIB-melanoom